Skip to content
10-K

Annual Report

OCUGEN, INC. OCGN

0001628280-26-014435

← back to feed
Filed
Mar 4, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 24, 2026 327.9M sh
Capex FY 2025 · Dec 31, 2025 $185K
Capex FY 2025 · Dec 31, 2024 $3.39M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$56.96M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$42.14M
Long Term Debt FY 2025 · Dec 31, 2025 $27.54M
Long Term Debt FY 2025 · Dec 31, 2024 $27.35M
Stockholders Equity FY 2025 · Dec 31, 2025 −$12.17M
Stockholders Equity FY 2025 · Dec 31, 2024 $29.63M
Stockholders Equity FY 2025 · Dec 31, 2023 $40.56M
Current Liabilities FY 2025 · Dec 31, 2025 $23.04M
Current Liabilities FY 2025 · Dec 31, 2024 $21.59M
Total Liabilities FY 2025 · Dec 31, 2025 $55.68M
Total Liabilities FY 2025 · Dec 31, 2024 $52.81M
Current Assets FY 2025 · Dec 31, 2025 $24.34M
Current Assets FY 2025 · Dec 31, 2024 $61.68M
Total Assets FY 2025 · Dec 31, 2025 $43.52M
Total Assets FY 2025 · Dec 31, 2024 $82.44M
Sga Expense FY 2025 · Dec 31, 2025 $27.58M
Sga Expense FY 2025 · Dec 31, 2024 $26.69M
Rd Expense FY 2025 · Dec 31, 2025 $39.75M
Rd Expense FY 2025 · Dec 31, 2024 $32.13M
Net Income FY 2025 · Dec 31, 2025 −$67.85M
Net Income FY 2025 · Dec 31, 2024 −$54.05M
Operating Income FY 2025 · Dec 31, 2025 −$62.92M
Operating Income FY 2025 · Dec 31, 2024 −$54.76M
Revenue FY 2025 · Dec 31, 2025 $4.41M
Revenue FY 2025 · Dec 31, 2024 $4.06M